{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:16:37Z","timestamp":1692735397337},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T00:00:00Z","timestamp":1183075200000},"content-version":"unspecified","delay-in-days":6998,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[1988,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Topical nasal phenylpropanolamine in a 2.5 per cent solution (PPA) was used in an evaluation of the possible development of tachyphylaxis and of possible effects on the mucociliary system after one week of treatment in healthy humans. The tendency of PPA to produce tachyphylaxis was evaluated by rhi-nomanometrie measurements of nasal airway resistance after repeated dose-response provocations. The mucociliary transport time was tested with the saccharine-dye test. No reduced dose-response effect or change in mucociliary transport time was found with PPA, thus indicating that one week of treatment does not contribute to such adverse effects.<\/jats:p>","DOI":"10.1017\/s0022215100105213","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T10:22:10Z","timestamp":1196418130000},"page":"408-410","source":"Crossref","is-referenced-by-count":5,"title":["Influence of topical phenypropanolamine on tachyphylaxis and mucociliary clearance in the human nose"],"prefix":"10.1017","volume":"102","author":[{"given":"K.","family":"Holmberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2007,6,29]]},"reference":[{"key":"S0022215100105213_ref018","volume-title":"Nasal Allergy","author":"Mygind","year":"1979"},{"key":"S0022215100105213_ref010","first-page":"50","article-title":"The \u201cnose drop nose\u201d due to oxymetazoline (Afrin) and other topical vasoconstrictors","volume":"140","author":"Feinberg","year":"1971","journal-title":"Illinois Medical Journal"},{"key":"S0022215100105213_ref026","unstructured":"Rijntjes E. (1985) Nose-drop abuse; a functional and morphological study. Thesis. Gravenhage."},{"key":"S0022215100105213_ref025","doi-asserted-by":"publisher","DOI":"10.3109\/00016488109138511"},{"key":"S0022215100105213_ref023","doi-asserted-by":"publisher","DOI":"10.3109\/00016488209128948"},{"key":"S0022215100105213_ref027","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198110000-00005"},{"key":"S0022215100105213_ref017","first-page":"140","volume-title":"Allergic and Vasomotor Rhinitis: Clinical Aspects","author":"Malm","year":"1985"},{"key":"S0022215100105213_ref015","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1945.02860060005002"},{"key":"S0022215100105213_ref016","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198207000-00013"},{"key":"S0022215100105213_ref004","first-page":"43","article-title":"Vascular effects of phenylpropanolamine on human nasal mucosa","volume":"23","author":"Bende","year":"1985","journal-title":"Rhinology"},{"key":"S0022215100105213_ref003","first-page":"33","article-title":"Rhinitis medicamentosa (an approach to treatment)","volume":"47","author":"Baldwin","year":"1977","journal-title":"Journal of the Medical Association of the State of Alabama"},{"key":"S0022215100105213_ref009","unstructured":"Federal Register (1976) VIII Nasal Decongestants, 41: 38396\u201338397."},{"key":"S0022215100105213_ref014","first-page":"181","article-title":"Mucociliary transport in the human nose\u2014effect of topical glucocorticoid treatment","volume":"23","author":"Holmberg","year":"1985","journal-title":"Rhinology"},{"key":"S0022215100105213_ref028","first-page":"21","volume-title":"Allergic and Vasomotor Rhinitis: Clinical Aspects","author":"Weeke","year":"1985"},{"key":"S0022215100105213_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8707(55)90033-2"},{"key":"S0022215100105213_ref024","unstructured":"Plym Forshell G. (1985) Absorption of phenylpropanolamine after intranasal administration. Internal report, LEO 1456F."},{"key":"S0022215100105213_ref019","first-page":"337","volume-title":"Essential Allergy","author":"Mygind","year":"1985"},{"key":"S0022215100105213_ref002","doi-asserted-by":"publisher","DOI":"10.1177\/000348948409300216"},{"key":"S0022215100105213_ref021","first-page":"167","article-title":"Treatment with xylometazoline (OtrivinR) nosedrops over a six-week period","volume":"19","author":"Petruson","year":"1981","journal-title":"Rhinology"},{"key":"S0022215100105213_ref008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1982.tb03132.x"},{"key":"S0022215100105213_ref007","doi-asserted-by":"publisher","DOI":"10.3109\/00016488209128900"},{"key":"S0022215100105213_ref012","volume-title":"The pharmacological basis of therapeutics","author":"Goodman","year":"1975"},{"key":"S0022215100105213_ref013","unstructured":"H\u00e2kansson B. and Toremalm N. G. (1984) Mucociliary function and nasal decongestants. Abstract. 10-Congres de la Soci\u00e9t\u00e9 Europ\u00e9enne de Rhinologie, Nancy."},{"key":"S0022215100105213_ref001","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1974.10666589"},{"key":"S0022215100105213_ref020","first-page":"377","volume-title":"The nose, upper airway physiology and the atmospheric environment","author":"Mygind","year":"1982"},{"key":"S0022215100105213_ref022","first-page":"89","volume-title":"Treatment of ear nose and throat infections","author":"Petruson","year":"1985"},{"key":"S0022215100105213_ref005","first-page":"881","article-title":"Rhinitis medicamentosa","volume":"19","author":"Black","year":"1980","journal-title":"Canadian Medical Association Journal"},{"key":"S0022215100105213_ref011","first-page":"205","article-title":"Rhinitis medicamentosa; conceptualization, incidence, and treatment","volume":"21","author":"Fleece","year":"1984","journal-title":"The Alabama Journal of Medical Science"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215100105213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T19:49:51Z","timestamp":1558381791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215100105213\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["S0022215100105213"],"URL":"https:\/\/doi.org\/10.1017\/s0022215100105213","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}